LEGNLegend Biotech Corporation
$19.27-40% 1Y
$19.27
$16.6552 weeks$36.28
Is the price fair?
What LEGN's price assumes
Legend Biotech Corporation did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 3.46× revenue.
3.46
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 3.56
Price / book · today's price, trailing year to Dec 31, 2025
- EV / sales
- 3.20
EV / sales
Details›
- Price / booktoday's price, trailing year to Dec 31, 2025
- 3.56
- EV / salestoday's price, trailing year to Dec 31, 2025
- 3.20
- Market capitalisation184.9 million shares, counted Dec 31, 2025
- $3.56B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Stocks with no debt